Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director · Chairman, President and CEO | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 83,191 |
Ending reported balance
After 2026-03-06 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 24,436 · Balance 92,118 Row 2 · 2026-03-06 · Tax withholding · Disposed 13,516 · Balance 78,602 F1: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Row 3 · 2026-03-06 · Exercise / conversion · Acquired 4,830 · Balance 83,432 Row 4 · 2026-03-06 · Tax withholding · Disposed 2,671 · Balance 80,761 F1: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Row 5 · 2026-03-06 · Exercise / conversion · Acquired 5,438 · Balance 86,199 Row 6 · 2026-03-06 · Tax withholding · Disposed 3,008 · Balance 83,191 F1: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-03-06 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-06 · Exercise / conversion · Disposed 24,436 · Balance 0 F2: Each RSU represents a contingent right to receive one share of Company common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-03-06 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-03-06 · Exercise / conversion · Disposed 4,830 · Balance 0 F2: Each RSU represents a contingent right to receive one share of Company common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-03-06 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-03-06 · Exercise / conversion · Disposed 5,438 · Balance 0 F2: Each RSU represents a contingent right to receive one share of Company common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
F2: Each RSU represents a contingent right to receive one share of Company common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 5,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · derivative · entry 9 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,438 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 4,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · derivative · entry 8 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,830 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 24,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · derivative · entry 7 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,436 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 3,008 | $92.54 | $278,360.32 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 6 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,191 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 5,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 5 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 2,671 | $92.54 | $247,174.34 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 4 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,761 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 13,516 | $92.54 | $1,250,770.64 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,602 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 24,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 19,090 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000006 · form4-02272026_090224.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,179 Underlying: Common Stock · 19,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 10,557 | $99.51 | $1,050,527.07 |
DisclosureSEC source: 0001757216-26-000006 · form4-02272026_090224.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,682 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 19,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000006 · form4-02272026_090224.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 65,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000004 · form4-02252026_010250.xml · derivative · entry 4 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,103 Underlying: Common Stock · 65,103 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F4 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000004 · form4-02252026_010250.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,995 Underlying: Common Stock · 15,996 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 8,846 | $98.62 | $872,392.52 |
DisclosureSEC source: 0001757216-26-000004 · form4-02252026_010250.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,149 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000004 · form4-02252026_010250.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 246 shares acquired under the Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 22:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 24,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000002 · form4-02232026_100236.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,436 Underlying: Common Stock · 24,436 shares Expires 2026-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned for both such grants to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 12,184 RSUs for March and 12,252 RSUs for September, totaling 24,436 RSUs, which will vest on March 6, 2026. F2 · derivative.underlying_shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned for both such grants to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 12,184 RSUs for March and 12,252 RSUs for September, totaling 24,436 RSUs, which will vest on March 6, 2026. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 10,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004971 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,268 Underlying: Common Stock · 10,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 10,268 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F3 · derivative.expiration_date: 10,268 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 5,679 | $104.86 | $595,499.94 |
DisclosureSEC source: 0001062993-25-004971 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,753 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 10,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004971 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 57,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003849 · form4.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,269 Underlying: Common Stock · 57,269 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003339 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,991 Underlying: Common Stock · 15,996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 8,846 | $103.46 | $915,207.16 |
DisclosureSEC source: 0001062993-25-003339 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,164 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003339 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 25,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002914 · form4.xml · derivative · entry 4 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,878 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 12,826 | $101.00 | $1,295,426.00 |
DisclosureSEC source: 0001062993-25-002914 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,014 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 25,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002914 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 209 shares acquired under the Employee Stock Purchase Plan through February 18, 2025. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 25,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002914 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,878 Underlying: Common Stock · 25,878 shares Expires 2025-02-18 F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · shares: On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 25,878 RSUs, which vested on February 18, 2025. F4 · derivative.underlying_shares: On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 25,878 RSUs, which vested on February 18, 2025. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 10,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006025 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,536 Underlying: Common Stock · 10,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 5,642 | $125.82 | $709,876.44 |
DisclosureSEC source: 0001062993-24-006025 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,753 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 10,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006025 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 7,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004689 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,513 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 3,028 | $128.80 | $390,006.40 |
DisclosureSEC source: 0001062993-24-004689 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,125 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 7,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004689 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 121 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 47,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004134 · form4.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,987 Underlying: Common Stock · 47,987 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 14,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017669 · form4.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,491 Underlying: Common Stock · 14,491 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests in increments of one-third on each of March 6, 2024, March 6, 2025 and March 6, 2026. F2 · derivative.expiration_date: Vests in increments of one-third on each of March 6, 2024, March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:27 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 16,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006285 · form4.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,315 Underlying: Common Stock · 16,315 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 4,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004633 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,011 shares Expires 2023-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 1,628 | $124.73 | $203,060.44 |
DisclosureSEC source: 0001062993-23-004633 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,519 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004633 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 65 shares acquired under the Company's Employee Stock Purchase Plan on December 30, 2022. Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · derivative · entry 9 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. F4 · derivative.expiration_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 954 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · derivative · entry 8 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 954 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. F4 · derivative.expiration_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · derivative · entry 7 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. F4 · derivative.expiration_date: On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 869 | $122.76 | $106,678.44 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 6 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,072 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 5 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 462 | $122.76 | $56,715.12 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 4 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,370 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 954 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 3 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 453 | $122.76 | $55,610.28 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,878 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| December 03, 2022 Filed Dec 6, 2022 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023419 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 203 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan since December 7, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006633 · form4.xml · derivative · entry 2 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,287 Underlying: Common Stock · 7,287 shares Expires 2024-02-25 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.